Danaher Corp. has emerged as the leading bidder for biotechnology supplier Abcam Plc, according to people familiar with the matter.
Danaher has pulled ahead of other bidders and is negotiating with the Cambridge, England-based company to reach a deal, the people said, asking not to be identified because the matter is private.
Nothing is finalized and talks could still fall apart. It’s still possible another bidder could prevail, the people said.
A representative for Abcam declined to comment. A representative for Danaher couldn’t immediately be reached for comment.
Bloomberg reported in June that Abcam had attracted initial interest from US life sciences company Danaher and Agilent Technologies Inc.
Abcam said in June that it was starting a process to explore strategic options including a sale after receiving interest from multiple parties.
https://www.bnnbloomberg.ca/danaher-is-in-the-lead-to-acquire-biotech-supplier-abcam-1.1963670
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.